Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, March 30 2017 4:52am ET - U.S. Markets open in 4 hours and 38 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Wednesday, Mar 29, 2017
·Checkmate: Starboard Boots Depomed CEO, Two Board Members
- Wed 11:33 am ET
·[$$] Starboard Wins More Board Seats, Replaces CEO at Depomed
at The Wall Street Journal Online - Wed 10:32 am ET
·Depomed Board of Directors Shaken Up While Insys Therapeutics Appoints a New CEO
- Wed 9:30 am ET
·Depomed Switches Out CEO and Board in Making Peace With Activist Starboard
at TheStreet.com - Wed 7:01 am ET
·Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results
GlobeNewswire - Wed 6:00 am ET
·Orexigen reports 4Q loss
AP - Tue 5:01 pm ET
Tuesday, Mar 28, 2017
·Depomed names new CEO
Reuters - Tue 4:32 pm ET
·Depomed dives as activist investor fight leads to new CEO, board members
at MarketWatch - Tue 4:22 pm ET
·Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
PR Newswire - Tue 4:21 pm ET
·Depomed Announces Cooperation Agreement with Starboard Value LP Including CEO and Board Changes
GlobeNewswire - Tue 4:03 pm ET
·Pernix Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results
GlobeNewswire - Tue 4:01 pm ET
·Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference
GlobeNewswire - Tue 4:01 pm ET
·MEI Pharma to Present at Needham Healthcare Conference
PR Newswire - Tue 9:00 am ET
·Risk-Reward With Teva Pharmaceutical
- Mon Mar 27
·Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Provisional Ratings to Nine CMBS Classes of Citigroup Commercial Mortgage Trust 2017-P7
- Mon Mar 27
·Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A. for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Italy
PR Newswire - Mon Mar 27
Monday, Mar 27, 2017
·Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use
PR Newswire - Mon Mar 27
·New fast-acting mealtime insulin, Fiasp®, now approved and available in Canada for the treatment of diabetes
PR Newswire - Mon Mar 27
·Synergy Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for TRULANCE™ (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
Business Wire - Mon Mar 27
·SciClone To Present At Needham Healthcare Conference On April 4, 2017
PR Newswire - Mon Mar 27
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?